(NYSEMKT: XTNT) Xtant Medical Holdings's forecast annual revenue growth rate of -13.24% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,548.38%.
Xtant Medical Holdings's revenue in 2026 is $133,083,000.On average, 4 Wall Street analysts forecast XTNT's revenue for 2026 to be $16,164,889,550, with the lowest XTNT revenue forecast at $13,898,780,922, and the highest XTNT revenue forecast at $18,390,956,966.
In 2027, XTNT is forecast to generate $17,643,334,325 in revenue, with the lowest revenue forecast at $15,161,059,150 and the highest revenue forecast at $20,080,808,143.